{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:55:22Z","timestamp":1773802522361,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA248475"],"award-info":[{"award-number":["CA248475"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA205247"],"award-info":[{"award-number":["CA205247"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA248475"],"award-info":[{"award-number":["CA248475"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA205247"],"award-info":[{"award-number":["CA205247"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41375-021-01423-x","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T19:02:52Z","timestamp":1632596572000},"page":"492-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Spred1 deficit promotes treatment resistance and transformation of chronic phase CML"],"prefix":"10.1038","volume":"36","author":[{"given":"Junjing","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Xuan Truong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinh Hoa","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan Rodriguez","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Elhajmoussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Ghoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony S.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-7292","authenticated-orcid":false,"given":"Haris","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-8766","authenticated-orcid":false,"given":"Danilo","family":"Perrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-016X","authenticated-orcid":false,"given":"Mhairi","family":"Copland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-1972","authenticated-orcid":false,"given":"Anjia","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4703-7524","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-5908","authenticated-orcid":false,"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"1423_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"1423_CR2","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120:2254\u201364.","journal-title":"J Clin Invest"},{"key":"1423_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11864-006-0012-y","volume":"7","author":"M Karbasian Esfahani","year":"2006","unstructured":"Karbasian Esfahani M, Morris EL, Dutcher JP, Wiernik PH. Blastic phase of chronic myelogenous leukemia. Curr Treat Options Oncol. 2006;7:189\u201399.","journal-title":"Curr Treat Options Oncol"},{"key":"1423_CR4","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/cas.13999","volume":"110","author":"T Kawazoe","year":"2019","unstructured":"Kawazoe T, Taniguchi K. The Sprouty\/Spred family as tumor suppressors: coming of age. Cancer Sci. 2019;110:1525\u201335.","journal-title":"Cancer Sci"},{"key":"1423_CR5","doi-asserted-by":"publisher","first-page":"23102","DOI":"10.1074\/jbc.M110.212662","volume":"286","author":"M Quintanar-Audelo","year":"2011","unstructured":"Quintanar-Audelo M, Yusoff P, Sinniah S, Chandramouli S, Guy GR. Sprouty-related Ena\/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras\/extracellular signal-regulated kinase (ERK) pathway. J Biol Chem. 2011;286:23102\u201312.","journal-title":"J Biol Chem"},{"key":"1423_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/35088082","volume":"412","author":"T Wakioka","year":"2001","unstructured":"Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature. 2001;412:647\u201351.","journal-title":"Nature"},{"key":"1423_CR7","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1038\/sj.onc.1207759","volume":"23","author":"K Miyoshi","year":"2004","unstructured":"Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, et al. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization. Oncogene. 2004;23:5567\u201376.","journal-title":"Oncogene"},{"key":"1423_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41375-021-01166-9","volume":"35","author":"LXT Nguyen","year":"2021","unstructured":"Nguyen LXT, Zhang B, Hoang DH, Zhao D, Wang H, Wu H, et al. Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia. Leukemia. 2021;35:2285\u201398.","journal-title":"Leukemia"},{"key":"1423_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/ng2113","volume":"39","author":"H Brems","year":"2007","unstructured":"Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007;39:1120\u20136.","journal-title":"Nat Genet"},{"key":"1423_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood-2009-04-218503","volume":"114","author":"E Pasmant","year":"2009","unstructured":"Pasmant E, Ballerini P, Lapillonne H, Perot C, Vidaud D, Leverger G, et al. SPRED1 disorder and predisposition to leukemia in children. Blood. 2009;114:1131.","journal-title":"Blood"},{"key":"1423_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/onc.2013.587","volume":"34","author":"E Pasmant","year":"2015","unstructured":"Pasmant E, Gilbert-Dussardier B, Petit A, de Laval B, Luscan A, Gruber A, et al. SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia. Oncogene. 2015;34:631\u20138.","journal-title":"Oncogene"},{"key":"1423_CR12","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"N Cancer Genome Atlas Research","year":"2013","unstructured":"Cancer Genome Atlas Research N, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl J Med. 2013;368:2059\u201374.","journal-title":"N. Engl J Med"},{"key":"1423_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/leu.2013.206","volume":"28","author":"L Olsson","year":"2014","unstructured":"Olsson L, Castor A, Behrendtz M, Biloglav A, Forestier E, Paulsson K, et al. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. Leukemia. 2014;28:302\u201310.","journal-title":"Leukemia"},{"key":"1423_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.stem.2018.04.002","volume":"22","author":"Y Tadokoro","year":"2018","unstructured":"Tadokoro Y, Hoshii T, Yamazaki S, Eto K, Ema H, Kobayashi M, et al. Spred1 safeguards hematopoietic homeostasis against diet-induced systemic stress. Cell Stem Cell. 2018;22:713\u201325 e718.","journal-title":"Cell Stem Cell"},{"key":"1423_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ccell.2015.12.011","volume":"29","author":"ER Lechman","year":"2016","unstructured":"Lechman ER, Gentner B, Ng SW, Schoof EM, van Galen P, Kennedy JA, et al. miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells. Cancer Cell. 2016;29:214\u201328.","journal-title":"Cancer Cell"},{"key":"1423_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nm.4499","volume":"24","author":"B Zhang","year":"2018","unstructured":"Zhang B, Nguyen LXT, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450\u201362.","journal-title":"Nat Med"},{"key":"1423_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood. 2005;105:324\u201334.","journal-title":"Blood"},{"key":"1423_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU, et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell. 2012;21:577\u201392.","journal-title":"Cancer Cell"},{"key":"1423_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20040616","volume":"201","author":"H Inoue","year":"2005","unstructured":"Inoue H, Kato R, Fukuyama S, Nonami A, Taniguchi K, Matsumoto K, et al. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J Exp Med. 2005;201:73\u201382.","journal-title":"J Exp Med"},{"key":"1423_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2443.2011.01529.x","volume":"16","author":"T Ishizaki","year":"2011","unstructured":"Ishizaki T, Tamiya T, Taniguchi K, Morita R, Kato R, Okamoto F, et al. miR126 positively regulates mast cell proliferation and cytokine production through suppressing Spred1. Genes Cells. 2011;16:803\u201314.","journal-title":"Genes Cells"},{"key":"1423_CR21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/nprot.2015.125","volume":"10","author":"AP Kusumbe","year":"2015","unstructured":"Kusumbe AP, Ramasamy SK, Starsichova A, Adams RH. Sample preparation for high-resolution 3D confocal imaging of mouse skeletal tissue. Nat Protoc. 2015;10:1904\u201314.","journal-title":"Nat Protoc"},{"key":"1423_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","volume":"15","author":"JE Fish","year":"2008","unstructured":"Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15:272\u201384.","journal-title":"Dev Cell"},{"key":"1423_CR23","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1242\/dev.029736","volume":"135","author":"F Kuhnert","year":"2008","unstructured":"Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development. 2008;135:3989\u201393.","journal-title":"Development"},{"key":"1423_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261\u201371.","journal-title":"Dev Cell"},{"key":"1423_CR25","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1128\/MCB.01600-06","volume":"27","author":"K Taniguchi","year":"2007","unstructured":"Taniguchi K, Kohno R, Ayada T, Kato R, Ichiyama K, Morisada T, et al. Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol. 2007;27:4541\u201350.","journal-title":"Mol Cell Biol"},{"key":"1423_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 2012;481:457\u201362.","journal-title":"Nature"},{"key":"1423_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature17624","volume":"532","author":"T Itkin","year":"2016","unstructured":"Itkin T, Gur-Cohen S, Spencer JA, Schajnovitz A, Ramasamy SK, Kusumbe AP, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323\u20138.","journal-title":"Nature"},{"key":"1423_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature12612","volume":"502","author":"Y Kunisaki","year":"2013","unstructured":"Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013;502:637\u201343.","journal-title":"Nature"},{"key":"1423_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12:329\u201341.","journal-title":"Cell Stem Cell"},{"key":"1423_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0","volume":"79","author":"MJ Boucher","year":"2000","unstructured":"Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N. MEK\/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem. 2000;79:355\u201369.","journal-title":"J Cell Biochem"},{"key":"1423_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jss.2008.05.017","volume":"152","author":"JM Galante","year":"2009","unstructured":"Galante JM, Mortenson MM, Bowles TL, Virudachalam S, Bold RJ. ERK\/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J Surg Res. 2009;152:18\u201325.","journal-title":"J Surg Res"},{"key":"1423_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM, Dunn K, Tardito S, Holyoake TL, et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med. 2017;23:1234\u201340.","journal-title":"Nat Med"},{"key":"1423_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/bies.20632","volume":"29","author":"K Bundschu","year":"2007","unstructured":"Bundschu K, Walter U, Schuh K. Getting a first clue about SPRED functions. Bioessays. 2007;29:897\u2013907.","journal-title":"Bioessays"},{"key":"1423_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2302\/kjm.58.73","volume":"58","author":"A Yoshimura","year":"2009","unstructured":"Yoshimura A. Regulation of cytokine signaling by the SOCS and Spred family proteins. Keio J Med. 2009;58:73\u201383.","journal-title":"Keio J Med"},{"key":"1423_CR35","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1101\/gad.341222.120","volume":"34","author":"C Lorenzo","year":"2020","unstructured":"Lorenzo C, McCormick F. SPRED proteins and their roles in signal transduction, development, and malignancy. Genes Dev. 2020;34:1410\u201321.","journal-title":"Genes Dev"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01423-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01423-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01423-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T09:09:32Z","timestamp":1643706572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01423-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1423"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01423-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"8 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient sample acquisition was approved by the Institutional Review Boards (IRB) at the COHNMC, in accordance with an assurance filed with and approved by the Department of Health and Human Services and met all requirements of the Declaration of Helsinki. CML patients were consented on the IRB #18067 protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}